Obesity per se, with one or two risk factors (defined as pre-MS patients) and MS patients have increased insulin secretion, hyperinsulinism, IR, increased thrombotic factors PAI-1 and low antioxidant protection. This evidence concerns the gene INS and myeloid sarcoma.